This review aims to summarize the current evidence on the treatment of viral hepatitis,
focusing on its clinical management. Also, future treatment options and areas of potential …

Hepatitis C virus (HCV) infections are emerging as one of the foremost challenges in
healthcare owing to its chronicity and the virus's quasispecies nature. Worldwide, over 170 …

Hepatitis C is a major health problem worldwide, frequently resulting in cirrhosis and
increasing the risk of hepatocellular carcinoma significantly. In recent years, the advent of …

This paper uses a unique dataset from Lebanon, a developing country with unstable political
conditions, to explore the drivers of research outcomes. We use the Negative Binomial …

Elbasvir and grazoprevir, in a fixed-dose combination of 50 and 100 mg, respectively, have
received approval to be administered orally once daily, with or without ribavirin, for the …

With a globally estimated 58 million people affected by, chronic hepatitis C virus (HCV)
infection still represents a hard challenge for scientific community. A chronic course can …

Globally, it is estimated that around 1.6 million individuals are infected with the hepatitis C
virus (HCV) every year. Chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC) are …

Globally, it is estimated that around 1.6 million individuals are infected with the hepatitis C
virus (HCV) every year. Chronic hepatitis, cirrhosis, and hepa-tocellular carcinoma (HCC) …

ABSTRACT A reliable and exact technique was formulated for concurrently determining
Elbasvir and Grazoprevir in tablet dosage forms. Chromatogram was developed by running …

There is a growing interest in assessment of future remnant liver function with 99m Tc-
mebrofenin hepatobiliary scintigraphy before major hepatectomy to estimate the risk of …